DxS and AstraZeneca collaborating on companion diagnostic
Gary Potikyan
Friday, 31 July 2009 21:00 UTC
DxS Diagnostic is now developing a companion diagnostic test to identify lung cancer patients who will respond to AstraZeneca’s Iressa (EGFR inhibitor).
-
Replies
